PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+54.17%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$347M
AUM Growth
+$347M
(+61%)
Cap. Flow
+$61.9M
Cap. Flow
% of AUM
17.87%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
89
New
22
Increased
24
Reduced
19
Closed
10
Top Buys
| 1 |
Humana
HUM
|
$11.6M |
| 2 |
Danaher
DHR
|
$8.84M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$8.83M |
| 4 |
Edwards Lifesciences
EW
|
$8.29M |
| 5 |
AbbVie
ABBV
|
$7.36M |
Top Sells
| 1 |
Merck
MRK
|
$6.96M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$6.63M |
| 3 |
Schrodinger
SDGR
|
$5.96M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.77M |
| 5 |
Intuitive Surgical
ISRG
|
$4.49M |
Sector Composition
| 1 | Healthcare | 91.97% |
| 2 | Technology | 0.91% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Karyopharm Therapeutics
KPTI
$61.4M
| $2.29M | 0.64% |
120,802
-95,000
| -44% | -$1.8M |
|
52
iRadimed
IRMD
$898M
| $2.2M | 0.62% |
94,717
-19,138
| -17% | -$444K |
|
53
Aurinia Pharmaceuticals
AUPH
$1.58B
| $2.12M | 0.6% |
130,288
+10,000
| +8% | +$162K |
|
54
Nephros
NEPH
$44M
| $2.11M | 0.59% |
251,366
| – | – |
|
55
Alphatec Holdings
ATEC
$2.35B
| $2.01M | 0.56% |
426,599
+50,000
| +13% | +$235K |
|
|
EIDX
56
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.96M | 0.55% |
41,085
-40,000
| -49% | -$1.91M |
|
|
BHVN
57
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.83M | 0.52% |
+25,000
| New | +$1.83M |
|
|
MSON
58
DELISTED
Misonix Inc
MSON
| $1.76M | 0.5% |
129,997
-20,003
| -13% | -$271K |
|
59
Immunic
IMUX
$79.4M
| $1.7M | 0.48% |
+140,000
| New | +$1.7M |
|
60
MeiraGTx Holdings
MGTX
$590M
| $1.69M | 0.48% |
135,000
+10,000
| +8% | +$125K |
|
61
Aprea Therapeutics
APRE
$8.91M
| $1.55M | 0.44% |
40,036
+10,000
| +33% | +$388K |
|
|
PVLA
62
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $1.42M | 0.4% |
458,843
-40,000
| -8% | -$124K |
|
|
63
Schrodinger
SDGR
$1.42B
| $1.37M | 0.39% |
15,000
-65,071
| -81% | -$5.96M |
|
64
QuidelOrtho
QDEL
$1.87B
| $1.34M | 0.38% |
+6,000
| New | +$1.34M |
|
65
Gyre Therapeutics
GYRE
$734M
| $1.26M | 0.36% |
215,237
| – | – |
|
66
RAPT Therapeutics
RAPT
$187M
| $1.16M | 0.33% |
+40,000
| New | +$1.16M |
|
67
Astria Therapeutics
ATXS
$394M
| $1M | 0.28% |
155,473
| – | – |
|
68
Mustang Bio
MBIO
$11.1M
| $965K | 0.27% |
303,376
| – | – |
|
69
MannKind Corp
MNKD
$1.69B
| $964K | 0.27% |
551,117
-350,000
| -39% | -$612K |
|
70
Castle Biosciences
CSTL
$673M
| $942K | 0.27% |
+25,000
| New | +$942K |
|
|
AMRN
71
Amarin Corp
AMRN
$311M
| $873K | 0.25% |
126,115
+50,000
| +66% | +$346K |
|
|
CDMO
72
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $821K | 0.23% |
+125,000
| New | +$821K |
|
|
SURF
73
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $820K | 0.23% |
+125,000
| New | +$820K |
|
74
Moderna
MRNA
$9.36B
| $642K | 0.18% |
10,000
-65,000
| -87% | -$4.17M |
|
75
Syndax Pharmaceuticals
SNDX
$1.39B
| $445K | 0.13% |
+30,000
| New | +$445K |
|